Irvine, California — August 29, 2025 — Leads & Copy — CG Oncology, Inc. (NASDAQ: CGON) announced that Chairman & Chief Executive Officer Arthur Kuan, and President & Chief Operating Officer Ambaw Bellete, are scheduled to participate in fireside chat presentations at the Cantor Global Healthcare Conference on Friday, September 5, 2025, at 10:20am ET in New York, NY and the Morgan Stanley 23rd Annual Global Healthcare Conference on Tuesday, September 9, 2025, at 7:45am ET in New York, NY.
Interested parties may access the live audio webcast from the Investor Relations section of the company’s website. The webcast replay will be available shortly after the conclusion of the live presentation and archived for approximately 90 days.
CG Oncology is a late-stage clinical biopharmaceutical company focused on developing and commercializing a potential backbone bladder-sparing therapeutic for bladder cancer patients.
Contact:
Sarah Connors
Vice President, Communications and Patient Advocacy, CG Oncology
sarah.connors@cgoncology.com
Megan Knight
Vice President, Investor Relations, CG Oncology
megan.knight@cgoncology.com
Source: CG Oncology
